Zenas BioPharma, Inc. Capital Expenditures
Zenas BioPharma, Inc. (ZBIO) reported Capital Expenditures of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.00K, a 88.89% decline year-over-year.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $18.00K, a 86.26% decline from fiscal 2024.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $131.00K, a 670.59% increase from fiscal 2023.
- Zenas BioPharma, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $17.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.00K 10-Q · filed 2026-08-13 | $2.00K derived: sum of 3 quarters · filed 2026-08-13 | $2.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-13 | $2.00K derived: sum of 2 quarters · filed 2026-05-13 | $2.00K derived: sum of 3 quarters · filed 2026-05-13 | $2.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $18.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $18.00K 10-Q · filed 2025-11-12 | $92.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $18.00K 10-Q · filed 2026-08-13 | $92.00K derived: sum of 3 quarters · filed 2026-08-13 | $92.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $18.00K 10-Q · filed 2026-05-13 | $92.00K derived: sum of 2 quarters · filed 2026-05-13 | $92.00K derived: sum of 3 quarters · filed 2026-05-13 | $127.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $74.00K derived: sum of 2 quarters · filed 2026-03-16 | $109.00K derived: sum of 3 quarters · filed 2026-03-16 | $131.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $35.00K derived: sum of 2 quarters · filed 2025-11-12 | $57.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $57.00K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $22.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $17.00K 10-K · filed 2025-03-11 |